Standard BioTools Inc. (NASDAQ:LAB) Q2 2023 Earnings Call Transcript August 8, 2023
Standard BioTools Inc. misses on earnings expectations. Reported EPS is $-0.22 EPS, expectations were $-0.21.
Operator: Hello, and welcome to the Standard BioTools Inc., Second Quarter 2023 Financial Results Conference Call. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Scott Greenstone, Vice President, Investor Relations and Business Development. Thank you....
